HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes.

AbstractOBJECTIVES:
Performance characteristics of the LOCI cTnI, CK-MB, MYO, NTproBNP and hsCRP methods on the Dimension Vista System were evaluated.
DESIGN AND METHODS:
Imprecision (following CLSI EP05-A2 guidelines), limit of quantitation (cTnI), limit of blank, linearity on dilution, serum versus plasma matrix studies (cTnI), and method comparison studies were conducted.
RESULTS:
Method imprecision of 1.8 to 9.7% (cTnI), 1.8 to 5.7% (CK-MB), 2.1 to 2.2% (MYO), 1.6 to 3.3% (NTproBNP), and 3.5 to 4.2% (hsCRP) were demonstrated. The manufacturer's claimed imprecision, detection limits and upper measurement limits were met. Limit of Quantitation was 0.040 ng/mL for the cTnI assay. Agreement of serum and plasma values for cTnI (r=0.99) was shown. Method comparison study results were acceptable.
CONCLUSIONS:
The Dimension Vista cTnI, CK-MB, MYO, NTproBNP, and hsCRP methods demonstrate acceptable performance characteristics for use as an aid in the diagnosis and risk assessment of patients presenting with suspected acute coronary syndromes.
AuthorsWalter E Kelley, Christina M Lockwood, Denise R Cervelli, Jamie Sterner, Mitchell G Scott, Show-Hong Duh, Robert H Christenson
JournalClinical biochemistry (Clin Biochem) Vol. 42 Issue 13-14 Pg. 1444-51 (Sep 2009) ISSN: 1873-2933 [Electronic] United States
PMID19523464 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Myoglobin
  • Peptide Fragments
  • Troponin I
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
  • C-Reactive Protein
  • Creatine Kinase, MB Form
Topics
  • Acute Coronary Syndrome (blood, diagnosis)
  • Biomarkers (blood)
  • C-Reactive Protein (analysis)
  • Cardiovascular Diseases (blood, diagnosis)
  • Creatine Kinase, MB Form (blood)
  • Humans
  • Immunoassay (instrumentation, methods)
  • Myoglobin (blood)
  • Natriuretic Peptide, Brain (blood)
  • Peptide Fragments (blood)
  • Reproducibility of Results
  • Risk Assessment
  • Sensitivity and Specificity
  • Troponin I (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: